Neuros Medical has received U.S. Food and Drug Administration approval to go ahead with a pilot trial of its electrical nerve block technology for amputation and residual limb pain....
Working in Ohio has been a major advantage for Neuros: Case Western Reserve University is one of the foremost organizations working on neurostimulation technology, and partner Battelle Labs in developing and manufacturing the first generation of devices for the research trials...
“We think this may have many applications in other areas treating patients with chronic pain,” said Jon Snyder, the president of Neuros, “including post-surgical pain, occipital neuralgia, which is a form of migraine, and a variety of other chronic pain conditions that are peripheral nerve based...."
Read the complete story.